L-isoleucine from Escherichia coli CCTCC M 20231916 in feed and water for drinking: IEC-VIS/FLD, endotoxins according to Ph. Eur. 2.6.14, specific optical rotation +36.25° below the pharmacopoeia range with 5.9 % valine

Commission Implementing Regulation (EU) 2026/1117, published on 27 May 2026, authorises until 16 June 2036 L-isoleucine (at least 90 % on a dry matter basis) produced by a genetically modified E. coli K12 derivative, CCTCC M 20231916, for all animal species, also in water for drinking despite EFSA’s concerns about hygiene and nutritional balance. User exposure to endotoxins is limited to 1 600 IU/m³ of air.

Source: Rozporządzenie wykonawcze Komisji (UE) 2026/1117 dotyczące zezwolenia na stosowanie L-izoleucyny wytwarzanej przy użyciu Escherichia coli CCTCC M 20231916 jako dodatku paszowego dla wszystkich gatunków zwierząt

Lab-News